| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/26/1992 | CN1015596B Preparation of riboflavin, produced by microbial method, in form of spray-dried granules of microgranules |
| 02/25/1992 | WO1992003438A1 Tricyclic benzodiazepine derivates their preparation and pharmaceutical compositions containing them |
| 02/25/1992 | WO1992003426A1 Piperazinyl derivatives |
| 02/25/1992 | WO1992003142A1 Composition for the topical treatment of psoriasis |
| 02/25/1992 | US5091576 Antipsoriasis, insecticides |
| 02/25/1992 | US5091569 Di-tert-butyl(hydroxy)phenylthio substituted hydroxamic acid derivatives |
| 02/25/1992 | US5091547 Phenylacetic acid derivative and process for making same |
| 02/25/1992 | US5091533 5-hydroxy-2,3-dihydrobenzofuran analogs as leukotriene biosynthesis inhibitors |
| 02/25/1992 | US5091531 N-imidaxo[1,2-b]pyridazinyl carbamates |
| 02/25/1992 | US5091530 Bactericides |
| 02/25/1992 | US5091528 6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as α adrenergic agents |
| 02/25/1992 | US5091524 Glycosidase inhibitor salbostatin, process for its preparation, and its use |
| 02/25/1992 | US5091523 Bactericides, antitumor agent |
| 02/25/1992 | US5091522 Retinoic esters of d-desosamine, process for their preparation and their use in human or veterinary medicine and in cosmetic compositions |
| 02/25/1992 | US5091521 Cis-platinum complexes, a process for the preparation thereof, and pharmaceuticals containing these compounds |
| 02/25/1992 | US5091510 Retro-inverso analogues of thymopentin, and their use in the preparation of pharmaceutical compositions |
| 02/25/1992 | US5091432 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use |
| 02/25/1992 | US5091429 Derivatives of 4-amino-1-trifluoromethyltetralines their preparation and their therapeutic application |
| 02/25/1992 | US5091427 Cognition activators |
| 02/25/1992 | US5091426 5-phenyl-2-furan ketones and use as antiepileptic agents |
| 02/25/1992 | US5091425 5-(heterocyclylalkanoyl)amino-4-hydroxypentanamides |
| 02/25/1992 | US5091422 Treating inflammatory or allergic skin disease, lowering gastric acidity |
| 02/25/1992 | US5091421 Chemical prevention or reversal of cataract by phase separation inhibitors |
| 02/25/1992 | US5091419 Anticholesterol agent |
| 02/25/1992 | US5091418 Novel alpha-glucosidase inhibitor, pradimicin Q |
| 02/25/1992 | US5091417 Preventive and therapeutic agent for hepatitis |
| 02/25/1992 | US5091415 Thioformamidines, their preparation and use as medicaments |
| 02/25/1992 | US5091413 Antibiotic agent |
| 02/25/1992 | US5091412 Novel antiviral terpene hydroquinones and methods of use |
| 02/25/1992 | US5091411 Bactericides, antibiotics |
| 02/25/1992 | US5091410 Thioxanthenone antitumor agents |
| 02/25/1992 | US5091409 4-alkylamino-6-(C3-5 -hydrocarbyl)thieno[2,3-B]thiopyran-2-sulfonamide-7,7-dioxides |
| 02/25/1992 | US5091404 Administering cyclocreatire, antiischemic agents |
| 02/25/1992 | US5091403 Sulfinyl imidazole derivatives and antiulcer agents containing the same |
| 02/25/1992 | US5091402 Use of substituted imidazoles |
| 02/25/1992 | US5091398 Substituted 1,2,3,4-oxatriazolium-5-olates, a process for their preparation and their use |
| 02/25/1992 | US5091397 1-aza-bicyclico(2.2.1)heptanes |
| 02/25/1992 | US5091394 Benzoylguanidines, a process for their preparation, their use as medicaments and medicaments containing them |
| 02/25/1992 | US5091393 Useful for treating schizophrenia, depression, epilepsy; vascular and respiratory system disorders |
| 02/25/1992 | US5091392 Substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphon-amides and -cyanamides, processes for their preparation and their use in medicaments |
| 02/25/1992 | US5091391 Method of resisting neurodegenerative disorders |
| 02/25/1992 | US5091389 Lipophilic macrolide useful as an immunosuppressant |
| 02/25/1992 | US5091388 Pyridobenzoindole derivatives, their preparation and compositions which contain them |
| 02/25/1992 | US5091386 7-substituted derivatives of 3,5-dihydroxyhept-6-ynoic acids and corresponding lactones and their use as hypercholeserolemics |
| 02/25/1992 | US5091384 Anti-bacterial quinolone- and naphthyridone-carboxylic acid compounds |
| 02/25/1992 | US5091383 Bactericides |
| 02/25/1992 | US5091382 Cephalosporin derivatives |
| 02/25/1992 | US5091380 N-monosubstituted adamantyl/norbornanyl 17β-carbamides of 3-carboxy-androst-3,5-dienes as testosterone 5α-reductase inhibitors |
| 02/25/1992 | US5091379 Dermatitis, side effect reduction |
| 02/25/1992 | US5091373 Administering sterile injectable solution of water, doxorubicin or salts and cosolubilizing agent; lyophilization |
| 02/25/1992 | US5091372 Method of treating tumors with pharmaceutical composition containing anthracycline glycosides |
| 02/25/1992 | US5091371 Antifungal and antiviral antibiotic, benanomicin A 4"'-O-sulfate or its salt, and the production and uses thereof |
| 02/25/1992 | US5091370 Angolamycin derivatives |
| 02/25/1992 | US5091369 Method of promoting endogenous fat oxidation |
| 02/25/1992 | US5091193 Zinc oxide, phytic acid and an ester of a fatty alcohol as anti-enzyme |
| 02/25/1992 | US5091191 Pharmaceutical composition with improved dissolution property |
| 02/25/1992 | US5091190 Delivery system for administration blood-glucose lowering drug |
| 02/25/1992 | US5091189 Tablet contains 3-alkylxanthine, hydrophilic or hydrophobic polymers, and wax from the group consists of polyalkylene glycol |
| 02/25/1992 | US5091184 Coated adhesive tablets |
| 02/25/1992 | US5091182 Gas-impermeable multilayer container comprised of polyolefin inner layer and metal foil outer layer |
| 02/25/1992 | US5091180 Protection against rhabdomyolysis-induced nephrotoxicity |
| 02/25/1992 | US5091175 Anticholesterol agents |
| 02/25/1992 | US5091171 Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use |
| 02/25/1992 | CA2089891A1 Tricyclic benzodiazepine derivatives their preparation and pharmaceutical compositions containing them |
| 02/25/1992 | CA2089768A1 Piperazinyl derivatives |
| 02/25/1992 | CA2067770A1 Composition for the topical treatment of psoriasis |
| 02/25/1992 | CA2049645A1 Phosphonate-containing pseudopeptides of the hydroxyethylamine and norstatin type |
| 02/25/1992 | CA2037120A1 Pyrrolidine derivatives and nootropic agents |
| 02/25/1992 | CA1296352C Aromatic dicyclic coumpounds, process for preparing such and use thereof in cosmetics |
| 02/25/1992 | CA1296344C 7-oxabicyclo(2.2.1)heptane analogs useful as inhibitors of 5-lipoxygenase and cyclooxygenase |
| 02/25/1992 | CA1296342C Anti-inflammatory agents, pharmaceutical compositions and methods for reducing inflammation |
| 02/25/1992 | CA1296341C Substituted di-t-butylphenols |
| 02/25/1992 | CA1296339C Antihyperlipidemic and antiatherosclerotic urea and carbamate compounds |
| 02/25/1992 | CA1296338C Diphenyl-methane derivative and pharmaceutical use |
| 02/25/1992 | CA1296337C Substituted 8-(phenylthio)-tetrahydroquinolines useful in the treatment of allergy |
| 02/25/1992 | CA1296336C 2-benzimidazolylalkylthio (or sulfinyl or sulfonyl) derivatives, their preparation and their application as medecine |
| 02/25/1992 | CA1296335C Dichloroaniline derivatives |
| 02/25/1992 | CA1296334C Substituted pyrimidoquinoxalines |
| 02/25/1992 | CA1296330C Method of treating viral infections in humans and compositins therefor |
| 02/25/1992 | CA1296329C Macrolide compounds |
| 02/25/1992 | CA1296328C Macrolide compounds |
| 02/25/1992 | CA1296326C Anthracycline derivatives having cytostatic activity |
| 02/25/1992 | CA1296325C Nitro anthracyclines, process for their preparation and use thereof |
| 02/25/1992 | CA1296322C Active principle isolated from shark tissue |
| 02/25/1992 | CA1296277C Salt of organogermanium compound and medicine containing the same |
| 02/25/1992 | CA1296254C Spheroids containing 3-alkylxanthine |
| 02/24/1992 | WO1992003453A1 Antiviral agent |
| 02/24/1992 | WO1992003425A1 Hypoglycemic hydroxyurea derivatives |
| 02/24/1992 | CA2087437A1 Hypoglycemic hydroxyurea derivatives |
| 02/24/1992 | CA2071915A1 Antiviral agent |
| 02/24/1992 | CA2049649A1 Codeine salt of a substituted carboxylic acid, processes for the preparation thereof, its use and pharmaceutical compositions |
| 02/24/1992 | CA2049497A1 Phosphonopyrrolidine-and piperidine-containing pseudopeptides of the statin type, a process for their preparation and their use as medicaments against retroviruses |
| 02/24/1992 | CA2048832A1 Antibiotic c-7 catechol-substituted cephalosporin compounds, compositions, and method of use thereof |
| 02/24/1992 | CA2048395A1 Method for preventing onset of or treating type iii hyperlipoproteinemia employing pravastatin |
| 02/24/1992 | CA2046771A1 Antibiotic c-3 di-hydroxyphenyl substituted cephalosporin compounds, compositions and method of use thereof |
| 02/24/1992 | CA2046442A1 Antibiotic c-3 catechol-substituted cephalosporin compounds, compositions and methods of use thereof |
| 02/22/1992 | CA2048003A1 Tricyclic pyridone derivatives |
| 02/21/1992 | WO1992003462A1 New phospholipid derivatives of nucleosides, their preparation and their use as antiviral drugs |
| 02/21/1992 | WO1992003138A1 Improvements in or relating to organic compounds |
| 02/21/1992 | WO1992003132A1 Indole derivatives which inhibit leukotriene biosynthesis |